Quality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic review.
<h4>Background</h4>Generic drugs are used by millions of patients for economic reasons, so their evaluation must be highly transparent.<h4>Objective</h4>To assess the quality of reporting of bioequivalence trials comparing generic to brand-name drugs.<h4>Methodology/pri...
Saved in:
| Main Authors: | Amélie van der Meersch, Agnès Dechartres, Philippe Ravaud |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0023611&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Planning and Evaluation of Bioequivalence Studies of Telmisartan Generic Drug Products
by: A. L. Khokhlov, et al.
Published: (2019-09-01) -
Generic versus brand-name cardiovascular drugs: a remarkable update.
by: Maria Elena Flacco, et al.
Published: (2015-12-01) -
Bioequivalence study of generic nirmatrelvir in healthy volunteers
by: R. A. Oseshnyuk, et al.
Published: (2023-05-01) -
BIOEQUIVALENCE STUDY OF GENERIC MOLNUPIRAVIR IN HEALTHY VOLUNTEERS
by: V. B. Vasilyuk, et al.
Published: (2023-02-01) -
Comparative Analysis of the Effectiveness of Generic and Brand-Name Cefepime: A Multicenter Retrospective Cohort Study
by: Chih-Huang Li, et al.
Published: (2025-01-01)